ISRCTN86885538已完成不适用
Taurolidine-citrate vs heparin as catheter lock solutions in paediatric patients
Tauropharm (Germany)0 个研究点目标入组 100 人开始时间: 2007年1月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Paediatric patients with newly implanted central venous catheters
排除标准
- •Bacteremia/sepsis ongoing; allergy against heparin or taurolidine
研究者
相似试验
Unknown
4 期
Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters.Hemodialysis Catheter InfectionDialysis Catheter ThrombosisNCT03539718Ain Shams University60
已完成
不适用
Trisodium citrate versus heparin for locking tunnelled haemodialysis catheters: a randomised controlled trialRenal failureISRCTN27307877Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
已完成
不适用
Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream InfectionsCatheter Related Blood Stream InfectionsIntestinal FailureNCT06660641Rigshospitalet, Denmark61
已完成
不适用
Double-blind clinical trial of taurolidine-citrate for the prevention of infection in patients using tunnelled lines for haemodialysisCatheter-related bacteraemiaInfections and InfestationsOther septicaemiaISRCTN51902376ancashire Teaching Hospitals NHS Foundation Trust (UK)100
已完成
4 期
Taurolidine Lock in Long Term Parenteral NutritionHome Parenteral NutritionCentral Venous CatheterNCT02009189Stanley Dudrick's Memorial Hospital30